Hematology/Oncology

Top Story

Open, robotic prostatectomy produce similar early functional outcomes

July 26, 2016

Robotic-assisted laparoscopic prostatectomy and open radical prostatectomy demonstrated similar 3-month postoperative outcomes for patients with localized prostate cancer, according to results of a randomized controlled phase 3 study.

Robot-assisted laparoscopic prostatectomy has been used since 2000; however, no head-to-head trial has yet compared the procedure with open radical prostatectomy.

Supplement

Meeting Update: ASCO highlights therapeutic advances in multiple cancer subtypes

HemOnc Today, July 25, 2016
Meeting Update: ASCO highlights therapeutic advances in multiple cancer subtypes Supplement
In the Journals

USPSTF finds insufficient evidence in favor of screening for skin cancer

July 26, 2016
There is not sufficient evidence to recommend visual skin examination by a clinician in screening for skin cancer in asymptomatic adults, the U.S. Preventive Services…

Scientists receive grants for pancreatic cancer research

July 26, 2016
The American Association for Cancer Research and Pancreatic Cancer Action Network presented nine grants to early-career scientists who intend to pursue research in…

Chemoimmunotherapy combination ‘new standard’ for CNS lymphoma

July 26, 2016
The addition of rituximab to thiotepa and methotrexate–cytarabine increased the complete remission rate among patients with central nervous system lymphoma…
More News Headlines »
CME

The Patient with Lymphadenopathy

No commercial support for this activity.

Castleman’s disease is a rare lymphoproliferative disorder that is characterized by enlargement of 1 (unicentric) or…
More »
Video
At Issue

VIDEO: BTK inhibitors, vaccines top contenders for combination immune strategies in lymphoma

July 18, 2016
More »
Featured
2016 ASCO Annual Meeting

2016 ASCO Annual Meeting

CME Video

Optimizing the Management of Metastatic Melanoma: Clinical Insights for Selecting First-line Therapy

This activity is supported by an independent educational grant from Merck & Co., Inc.

The incidence of melanoma is continuing to increase worldwide. In recent years, the treatment landscape for this…
More »
Current Issues
View the Current Issue
HemOnc Today
morganatic-roan
morganatic-roan